Zydus Cadila acquires Biochem Pharmaceuticals

21 Dec 2011

1

India's fifth largest pharmaceutical company Zydus Cadila today acquired Biochem Pharmaceuticals for an undisclosed amount, its third acquisition this year and eighth since 2003.

Founded in 1959, the privately held Mumbai based Biochem, produces a wide range antibiotics in the cardiovascular, anti-diabetic and oncological segment.

Biochem's antibiotics Amicin or amikasin is used for dermatological treatment, while its Ampilox and Biotax, are used as anti-infectives.

Its top five drugs, Amicin, Ampilox, Biotex, Monotax and Zithrocin, contribute 40 per cent of the company's sales.

The company exports products to eight countries and for the financial year 2010-11, Biochem reported revenues of Rs264.5 crore

"We have looked at every strategic opportunity to grow and contribute to this market [formulations], either by way of novel initiatives, collaborations or acquisitions," said Pankaj Patel, Zydus Cadila's chairman and managing director.

Business History Videos

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more